SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-091895
Filing Date
2024-08-06
Accepted
2024-08-06 16:30:28
Documents
70
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q snse-20240630.htm   iXBRL 10-Q 1833427
2 EX-31.1 snse-ex31_1.htm EX-31.1 15211
3 EX-31.2 snse-ex31_2.htm EX-31.2 16325
4 EX-32.1 snse-ex32_1.htm EX-32.1 9484
  Complete submission text file 0000950170-24-091895.txt   7301624

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT snse-20240630.xsd EX-101.SCH 1169652
73 EXTRACTED XBRL INSTANCE DOCUMENT snse-20240630_htm.xml XML 983674
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39980 | Film No.: 241179835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)